165 related articles for article (PubMed ID: 32740865)
1. Optimal target b-value on computed diffusion-weighted magnetic resonance imaging for visualization of pancreatic ductal adenocarcinoma and focal autoimmune pancreatitis.
Ichikawa S; Kromrey ML; Motosugi U; Onishi H
Abdom Radiol (NY); 2021 Feb; 46(2):636-646. PubMed ID: 32740865
[TBL] [Abstract][Full Text] [Related]
2. Computed diffusion-weighted MR imaging for visualization of pancreatic adenocarcinoma: Comparison with acquired diffusion-weighted imaging.
Fukukura Y; Kumagae Y; Hakamada H; Shindo T; Takumi K; Kamimura K; Nakajo M; Umanodan A; Yoshiura T
Eur J Radiol; 2017 Oct; 95():39-45. PubMed ID: 28987696
[TBL] [Abstract][Full Text] [Related]
3. Optimizing b-values for accurate depiction of pancreatic cancer with tumor-associated pancreatitis on computed diffusion-weighted imaging.
Tokunaga K; Arizono S; Shimizu H; Fujimoto K; Kurata M; Minamiguchi S; Isoda H; Togashi K
Clin Imaging; 2020 May; 61():20-26. PubMed ID: 31954347
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and Diagnostic Performance of Voxelwise Computed Diffusion-Weighted Imaging in Breast Cancer.
Zhou J; Chen E; Xu H; Ye Q; Li J; Ye S; Cheng Q; Zhao L; Su MY; Wang M
J Magn Reson Imaging; 2019 Jun; 49(6):1610-1616. PubMed ID: 30328211
[TBL] [Abstract][Full Text] [Related]
5. The role of apparent diffusion coefficient value in the diagnosis of localized type 1 autoimmune pancreatitis: differentiation from pancreatic ductal adenocarcinoma and evaluation of response to steroids.
Sekito T; Ishii Y; Serikawa M; Tsuboi T; Kawamura R; Tsushima K; Nakamura S; Hirano T; Fukiage A; Mori T; Ikemoto J; Kiyoshita Y; Saeki S; Tamura Y; Miyamoto S; Chayama K
Abdom Radiol (NY); 2021 May; 46(5):2014-2024. PubMed ID: 33386451
[TBL] [Abstract][Full Text] [Related]
6. Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma.
Jia H; Li J; Huang W; Lin G
BMC Med Imaging; 2021 Oct; 21(1):149. PubMed ID: 34654379
[TBL] [Abstract][Full Text] [Related]
7. Effective apparent diffusion coefficient parameters for differentiation between mass-forming autoimmune pancreatitis and pancreatic ductal adenocarcinoma.
Ren H; Mori N; Hamada S; Takasawa C; Mugikura S; Masamune A; Takase K
Abdom Radiol (NY); 2021 Apr; 46(4):1640-1647. PubMed ID: 33037891
[TBL] [Abstract][Full Text] [Related]
8. Conspicuity of peripheral zone prostate cancer on computed diffusion-weighted imaging: comparison of cDWI1500, cDWI2000, and cDWI3000.
Vural M; Ertaş G; Onay A; Acar Ö; Esen T; Sağlıcan Y; Zengingönül HP; Akpek S
Biomed Res Int; 2014; 2014():768291. PubMed ID: 25525603
[TBL] [Abstract][Full Text] [Related]
9. Quantitative evaluation of computed and voxelwise computed diffusion-weighted imaging in breast cancer.
Cheng Q; Ye S; Fu C; Zhou J; He X; Miao H; Xu N; Wang M
Br J Radiol; 2019 Aug; 92(1100):20180978. PubMed ID: 31291125
[TBL] [Abstract][Full Text] [Related]
10. Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings.
Choi SY; Kim SH; Kang TW; Song KD; Park HJ; Choi YH
AJR Am J Roentgenol; 2016 Feb; 206(2):291-300. PubMed ID: 26797355
[TBL] [Abstract][Full Text] [Related]
11. Radiomics based on diffusion-weighted imaging for differentiation between focal-type autoimmune pancreatitis and pancreatic carcinoma.
Shiraishi M; Igarashi T; Hiroaki F; Oe R; Ohki K; Ojiri H
Br J Radiol; 2022 Dec; 95(1140):20210456. PubMed ID: 35946923
[TBL] [Abstract][Full Text] [Related]
12. MRI features for differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
Ha J; Choi SH; Kim KW; Kim JH; Kim HJ
Dig Liver Dis; 2022 Jul; 54(7):849-856. PubMed ID: 34903501
[TBL] [Abstract][Full Text] [Related]
13. The use of magnetic resonance elastography in differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A preliminary study.
Shi Y; Cang L; Zhang X; Cai X; Wang X; Ji R; Wang M; Hong Y
Eur J Radiol; 2018 Nov; 108():13-20. PubMed ID: 30396645
[TBL] [Abstract][Full Text] [Related]
14. Multifocal autoimmune pancreatitis: A retrospective study in a single tertiary center of 26 patients with a 20-year literature review.
Huang XM; Shi ZS; Ma CL
World J Gastroenterol; 2021 Jul; 27(27):4429-4440. PubMed ID: 34366614
[TBL] [Abstract][Full Text] [Related]
15. Use of MRI signal intensity ratio to differentiate between autoimmune pancreatitis and pancreatic ductal adenocarcinoma.
Lu S; Liang J; Liao S; Wu D; Wu F; Li H
Clin Radiol; 2022 Jan; 77(1):e84-e91. PubMed ID: 34756699
[TBL] [Abstract][Full Text] [Related]
16. Application of dynamic contrast enhanced ultrasound in distinguishing focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Qiu YJ; Zhao GC; Shi SN; Zuo D; Zhang Q; Dong Y; Lou WH; Wang WP
Clin Hemorheol Microcirc; 2022; 81(2):149-161. PubMed ID: 35253737
[TBL] [Abstract][Full Text] [Related]
17. Differentiating focal autoimmune pancreatitis and pancreatic ductal adenocarcinoma: contrast-enhanced MRI with special emphasis on the arterial phase.
Kwon JH; Kim JH; Kim SY; Byun JH; Kim HJ; Lee MG; Lee SS
Eur Radiol; 2019 Nov; 29(11):5763-5771. PubMed ID: 31028441
[TBL] [Abstract][Full Text] [Related]
18. Intravoxel incoherent motion diffusion-weighted imaging of the pancreas: Characterization of benign and malignant pancreatic pathologies.
Kim B; Lee SS; Sung YS; Cheong H; Byun JH; Kim HJ; Kim JH
J Magn Reson Imaging; 2017 Jan; 45(1):260-269. PubMed ID: 27273754
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of focal autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Lopes Vendrami C; Shin JS; Hammond NA; Kothari K; Mittal PK; Miller FH
Abdom Radiol (NY); 2020 May; 45(5):1371-1386. PubMed ID: 31493022
[TBL] [Abstract][Full Text] [Related]
20. Radiomics model of dual-time 2-[
Liu Z; Li M; Zuo C; Yang Z; Yang X; Ren S; Peng Y; Sun G; Shen J; Cheng C; Yang X
Eur Radiol; 2021 Sep; 31(9):6983-6991. PubMed ID: 33677645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
